Advertisement
Screener

Lakewood-Amedex Biotherapeutics Inc. (LABT) Scorecard

2.8 / 5 stars · 68/120 Roast Me

Lakewood-Amedex Biotherapeutics Inc. (LABT) Scorecard

  • 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
40 QUARTERS × 3 ROAST BATTLES
0/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 0 wins, 12 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

QuarterTotal returnRevenue growthEPS growth
2026-Q20/3 LoseLABT / S&P
LABT unavailable / 15.20% 		LoseLABT / S&P
LABT unavailable / 15.00% 		LoseLABT / S&P
LABT unavailable / 50.40%
2026-Q10/3 LoseLABT / S&P
LABT unavailable / -4.33% 		LoseLABT / S&P
LABT unavailable / 11.30% 		LoseLABT / S&P
LABT unavailable / 27.70%
2025-Q40/3 LoseLABT / S&P
LABT unavailable / 2.65% 		LoseLABT / S&P
LABT unavailable / 9.00% 		LoseLABT / S&P
LABT unavailable / 13.40%
2025-Q30/3 LoseLABT / S&P
LABT unavailable / 8.12% 		LoseLABT / S&P
LABT unavailable / 4.61% 		LoseLABT / S&P
LABT unavailable / 13.45%
2025-Q20/3 LoseLABT / S&P
LABT unavailable / 10.94% 		LoseLABT / S&P
LABT unavailable / 4.83% 		LoseLABT / S&P
LABT unavailable / 10.63%
2025-Q10/3 LoseLABT / S&P
LABT unavailable / -4.27% 		LoseLABT / S&P
LABT unavailable / 4.98% 		LoseLABT / S&P
LABT unavailable / 10.57%
2024-Q40/3 LoseLABT / S&P
LABT unavailable / 2.41% 		LoseLABT / S&P
LABT unavailable / 5.25% 		LoseLABT / S&P
LABT unavailable / 6.15%
2024-Q30/3 LoseLABT / S&P
LABT unavailable / 5.89% 		LoseLABT / S&P
LABT unavailable / 5.89% 		LoseLABT / S&P
LABT unavailable / 6.11%
2024-Q20/3 LoseLABT / S&P
LABT unavailable / 4.28% 		LoseLABT / S&P
LABT unavailable / 5.38% 		LoseLABT / S&P
LABT unavailable / 5.12%
2024-Q10/3 LoseLABT / S&P
LABT unavailable / 10.56% 		LoseLABT / S&P
LABT unavailable / 5.71% 		LoseLABT / S&P
LABT unavailable / 5.59%
2023-Q40/3 LoseLABT / S&P
LABT unavailable / 11.69% 		LoseLABT / S&P
LABT unavailable / 6.81% 		LoseLABT / S&P
LABT unavailable / 7.78%
2023-Q30/3 LoseLABT / S&P
LABT unavailable / -3.27% 		LoseLABT / S&P
LABT unavailable / 7.52% 		LoseLABT / S&P
LABT unavailable / -5.03%
2023-Q20/3 LoseLABT / S&P
LABT unavailable / 8.74% 		LoseLABT / S&P
LABT unavailable / 9.50% 		LoseLABT / S&P
LABT unavailable / -8.57%
2023-Q10/3 LoseLABT / S&P
LABT unavailable / 7.50% 		LoseLABT / S&P
LABT unavailable / 10.77% 		LoseLABT / S&P
LABT unavailable / -15.69%
2022-Q40/3 LoseLABT / S&P
LABT unavailable / 7.56% 		LoseLABT / S&P
LABT unavailable / 11.88% 		LoseLABT / S&P
LABT unavailable / -17.99%
2022-Q30/3 LoseLABT / S&P
LABT unavailable / -4.88% 		LoseLABT / S&P
LABT unavailable / 13.47% 		LoseLABT / S&P
LABT unavailable / -1.41%
2022-Q20/3 LoseLABT / S&P
LABT unavailable / -16.10% 		LoseLABT / S&P
LABT unavailable / 13.71% 		LoseLABT / S&P
LABT unavailable / 11.04%
2022-Q10/3 LoseLABT / S&P
LABT unavailable / -4.60% 		LoseLABT / S&P
LABT unavailable / 15.97% 		LoseLABT / S&P
LABT unavailable / 42.23%
2021-Q40/3 LoseLABT / S&P
LABT unavailable / 11.03% 		LoseLABT / S&P
LABT unavailable / 15.00% 		LoseLABT / S&P
LABT unavailable / 96.40%
2021-Q30/3 LoseLABT / S&P
LABT unavailable / 0.58% 		LoseLABT / S&P
LABT unavailable / 10.77% 		LoseLABT / S&P
LABT unavailable / 69.42%
2021-Q20/3 LoseLABT / S&P
LABT unavailable / 8.55% 		LoseLABT / S&P
LABT unavailable / 6.58% 		LoseLABT / S&P
LABT unavailable / 51.81%
2021-Q10/3 LoseLABT / S&P
LABT unavailable / 6.17% 		LoseLABT / S&P
LABT unavailable / -1.06% 		LoseLABT / S&P
LABT unavailable / 7.39%
2020-Q40/3 LoseLABT / S&P
LABT unavailable / 12.15% 		LoseLABT / S&P
LABT unavailable / -3.72% 		LoseLABT / S&P
LABT unavailable / -33.42%
2020-Q30/3 LoseLABT / S&P
LABT unavailable / 8.93% 		LoseLABT / S&P
LABT unavailable / -2.04% 		LoseLABT / S&P
LABT unavailable / -27.10%
2020-Q20/3 LoseLABT / S&P
LABT unavailable / 20.54% 		LoseLABT / S&P
LABT unavailable / -0.46% 		LoseLABT / S&P
LABT unavailable / -27.11%
2020-Q10/3 LoseLABT / S&P
LABT unavailable / -19.60% 		LoseLABT / S&P
LABT unavailable / 3.47% 		LoseLABT / S&P
LABT unavailable / -14.75%
2019-Q40/3 LoseLABT / S&P
LABT unavailable / 9.07% 		LoseLABT / S&P
LABT unavailable / 5.36% 		LoseLABT / S&P
LABT unavailable / 2.99%
2019-Q30/3 LoseLABT / S&P
LABT unavailable / 1.70% 		LoseLABT / S&P
LABT unavailable / 5.02% 		LoseLABT / S&P
LABT unavailable / 0.21%
2019-Q20/3 LoseLABT / S&P
LABT unavailable / 4.30% 		LoseLABT / S&P
LABT unavailable / 6.64% 		LoseLABT / S&P
LABT unavailable / 8.65%
2019-Q10/3 LoseLABT / S&P
LABT unavailable / 13.65% 		LoseLABT / S&P
LABT unavailable / 8.12% 		LoseLABT / S&P
LABT unavailable / 14.29%
2018-Q40/3 LoseLABT / S&P
LABT unavailable / -13.52% 		LoseLABT / S&P
LABT unavailable / 9.05% 		LoseLABT / S&P
LABT unavailable / 18.23%
2018-Q30/3 LoseLABT / S&P
LABT unavailable / 7.71% 		LoseLABT / S&P
LABT unavailable / 10.21% 		LoseLABT / S&P
LABT unavailable / 19.06%
2018-Q20/3 LoseLABT / S&P
LABT unavailable / 3.43% 		LoseLABT / S&P
LABT unavailable / 9.03% 		LoseLABT / S&P
LABT unavailable / 14.46%
2018-Q10/3 LoseLABT / S&P
LABT unavailable / -0.76% 		LoseLABT / S&P
LABT unavailable / 7.68% 		LoseLABT / S&P
LABT unavailable / 12.46%
2017-Q40/3 LoseLABT / S&P
LABT unavailable / 6.64% 		LoseLABT / S&P
LABT unavailable / 7.03% 		LoseLABT / S&P
LABT unavailable / 13.82%
2017-Q30/3 LoseLABT / S&P
LABT unavailable / 4.48% 		LoseLABT / S&P
LABT unavailable / 5.68% 		LoseLABT / S&P
LABT unavailable / 17.57%
2017-Q20/3 LoseLABT / S&P
LABT unavailable / 3.09% 		LoseLABT / S&P
LABT unavailable / 4.83% 		LoseLABT / S&P
LABT unavailable / 17.74%
2017-Q10/3 LoseLABT / S&P
LABT unavailable / 6.07% 		LoseLABT / S&P
LABT unavailable / 3.67% 		LoseLABT / S&P
LABT unavailable / 13.32%
2016-Q40/3 LoseLABT / S&P
LABT unavailable / 3.82% 		LoseLABT / S&P
LABT unavailable / 2.09% 		LoseLABT / S&P
LABT unavailable / 7.05%
2016-Q30/3 LoseLABT / S&P
LABT unavailable / 3.85% 		LoseLABT / S&P
LABT unavailable / 0.20% 		LoseLABT / S&P
LABT unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2026-04-23 to 2026-08-27

MetricLABT total returnS&P 500 Total Return Index
Total return-97.12%20.78%
Annualized return-97.12%20.78%

5Y · 2026-04-23 to 2026-08-27

MetricLABT total returnS&P 500 Total Return Index
Total return-97.12%83.14%
Annualized return-50.81%12.86%

10Y · 2026-04-23 to 2026-08-27

MetricLABT total returnS&P 500 Total Return Index
Total return-97.12%319.30%
Annualized return-29.87%15.41%

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)United States$0.005B
Dermata Therapeutics, Inc. (DRMA)United States$0.005B-0.62
REVELATION BIOSCIENCES, INC. (REVB)United States$0.004B
HCW Biologics Inc. (HCWB)United States$0.004B-6.15
Onconetix, Inc. (ONCO)United States$0.004B
AMARIN CORP PLC\UK (AMRN)$0.005B-247.24
Aptevo Therapeutics Inc. (APVO)United States$0.003B
Processa Pharmaceuticals, Inc. (PCSA)United States$0.005B
Advertisement